AstraZeneca and Eli Lilly are to combine...
Ad Right Top
Xifaxan® 550 mg is the first-and-only nonsystemic...
Gilead Alberta ULC, a subsidiary of Gilead...
April 2015 Focus: Healthcare Communications Agencies
- Threat and Expense of Antitrust Litigation Grows in the Health Care Sector; ACE Report Identifies Due Diligence Practices to Help Mitigate Risk
- 21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry
- The Future of Personalized Health Marketing
Ad Right Bottom
- Scores of Hollywood Celebrities Including Stars from Mad Men, Dancing with the Stars, General Hospital, UFC, White Collar, Sex and the City, Austin Powers and Many Others Bet Big To Beat Cancer at 2nd Annual Tower Cancer Research Foundation Cancer F
- AbelsonTaylor Honors World Hunger Day
- Six Disruptions Healthcare Marketing Agencies Need to Know
- AstraZeneca and Lilly to test new cancer drug combination
- Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)
- FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics